Aamir AhmadProf. Aamir Ahmad, PhD is a distinguished cancer experimenter, Experienced Scientist and Group Leader of Epigenetics Research at the Translational Research Institute, Hamad Medical Corporation, Qatar. With expansive experience in oncology, epienetics, and translational drug, he has held crucial academic and exploration positions at institutions like the University of Alabama at Birmingham, University of South Alabama, and Wayne State University. Prof. Ahmad's work focuses on cancer epigenetics, medicine resistance, and tumor microenvironment, with over 250 peer reviewed publications, 20,000 citations and an h- indicator of 69. honored among the top 2 of scientists for career-long impact, he serves as Editor- in- Chief of Non-coding RNA exploration and leads multiple funded systems on cancer therapeutics. A plentiful author, speaker, and grant critic, his patronages have shaped advancements in perfection drug and targeted therapeutic regimes for cancer. Read More Read Less